A Phase 2/3 Open-Label, Single-Arm Trial to Evaluate the Safety and Activity of Eculizumab in Pediatric Patients with Relapsing Neuromyelitis Optica Spectrum Disorder
Clinical Trial Grant
Administered By
Pediatrics, Rheumatology
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
November 30, 2020
End Date
November 30, 2022
Administered By
Pediatrics, Rheumatology
Awarded By
Alexion Pharmaceuticals, Inc.
Start Date
November 30, 2020
End Date
November 30, 2022